Perceptive Advisors LLC 13D and 13G filings for Fusion Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-19 4:37 pm Purchase | 2024-01-09 | 13G | Fusion Pharmaceuticals Inc. FUSN | Perceptive Advisors LLC | 4,737,194 6.500% | 4,737,194 (New Position) | Filing |